{
    "N/R/U": null,
    "Applicant": "Boehringer Ingelheim Pharma GmbH & Co. KG",
    "BLA Number": "103769",
    "Proprietary Name": "Verluma",
    "Proper Name": "nofetumomab",
    "BLA Type": "351(a)",
    "Strength": "10MG/ML",
    "Dosage Form": "Injection ",
    "Route of Administration": "Intravenous",
    "Product Presentation": null,
    "Marketing Status": "Disc",
    "Licensure": "Voluntarily Revoked",
    "Approval Date": "October 13, 1998",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": null,
    "Submission Type": null,
    "License Number": "1251",
    "Product Number": "001",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null,
    "drug": [
        {
            "name": "nofetumomab"
        }
    ]
}